Catalyst
Slingshot members are tracking this event:
AMAG Pharmaceuticals (AMAG) preparing for sNDA submission on Makena, a treatment to reduce preterm birth, in the second quarter of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMAG | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 17, 2017
Occurred Source:
https://www.amagpharma.com/news/amag-submits-supplemental-new-drug-application-to-fda-for-makena-hydroxyprogesterone-caproate-injection-auto-injector-for-subcutaneous-use/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Snda, Makena, Preterm Birth
